| [1] Goff SP. Retroviral reverse transcriptase: Synthesis, structure, and function [J] J Acquir Immune Defic Syndr, 1990, 3: 817–831.
[2] Mitsuya H, Broder S. Strategies for antiviral therapy in AIDS [J] Nature, 1987, 325: 773.
[3] Baba M, Debyser Z, Clercq ED. Highly potent selective inhibition of human immunodeficiency virus type 1 (HIV) by the HIV-1 specific reverse transcriptase inhibitors. [J] Drugs Future, 1992, 17: 891.
[4] Furman PA, Fyfe JA, Freeman GA, et al. Phosphorylation of -azdio--deoxy-thymidine and selective interaction of the -triphosphate with human immunodeficiency virus reverse transcriptase [J]. Proc Natl Acad Sci USA, 1986, 83: 8333.
[5] St. Clair MH, Richards CA, et al. -Azdio-deoxythy-midine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase [J]. Antimicrob Agents Chemother, 1987, 31: 1972.
[6] Yachoan R, Mitsuya H, et al. In vivo activity against HIV and favorable toxicity profile of , -dideoxyinosine [J]. Science, 1989, 245: 412–441.
[7] Merluzzi VJ, Hargrave KD, et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor [J]. Science, 1990, 250: 1411–1413.
[8] Pauwels R, Andries K, et al. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives [J]. Nature, 1990, 343: 470.
[9] Miyasaka T, Tanaka H, Baba M, et al. A new lead for specific anti-HIV-1 agents: 1-[(2-Hydroxyethoxy) methyl]-6-(phenylthio)-thymine [J]. J Med Chem, 1989, 32: 2507.
[10] Danel K, Pedersen EB, Nielsen C. Synthesis and anti-HIV-1 activity of novel 2, 3-dihydro-7H-thiazolo [3, 2-a] pyrimidine-7-ones [J]. J Med Chem, 1998, 41: 191. |
>
>